1.Cancer Therapy with Phytochemicals: Present and Future Perspectives.
Biomedical and Environmental Sciences 2015;28(11):808-819
Recently, a wide range of food-derived phytochemical compounds and their synthetic derivatives have been proposed for cancer treatment. Unfortunately, data available in related literature focus on the anti-cancer properties of compounds derived from edible plants, while very little is known about those derived from non-edible plants. And thus, the underlying mechanisms of their anti-cancer effects are yet to be elucidated. This review collates the available data on the anti-cancer activities of six phytochemical-derived compounds from edible and non-edible plants, i.e. rottlerin, berbamine, sparstolonin B, sulforaphane, plumbagin and 6-shogaol. These compounds are used as bioactive markers for cytotoxicity against tumors. As such, understanding their mode of action will provide the rationale for the combination strategies of these compounds with other drugs in the battle against cancer.
Acetophenones
;
pharmacology
;
therapeutic use
;
Antineoplastic Agents, Phytogenic
;
pharmacology
;
therapeutic use
;
Benzopyrans
;
pharmacology
;
therapeutic use
;
Benzylisoquinolines
;
pharmacology
;
therapeutic use
;
Catechols
;
pharmacology
;
therapeutic use
;
Heterocyclic Compounds, 4 or More Rings
;
pharmacology
;
therapeutic use
;
Humans
;
Isothiocyanates
;
pharmacology
;
therapeutic use
;
Naphthoquinones
;
pharmacology
;
therapeutic use
;
Neoplasms
;
drug therapy
;
Phytotherapy
;
Plant Extracts
;
pharmacology
;
therapeutic use
;
Signal Transduction
;
drug effects
2.Jug-PLGA-NPs, a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma.
Wu-Heng YUE ; Lan-Qun QIN ; Juan CAI ; Rui MEI ; Han-Qing QIAN ; Zheng-Yun ZOU
Chinese journal of integrative medicine 2022;28(10):909-917
OBJECTIVE:
To verrify the anti-tumor efficacy and toxicity between juglone (Jug) and Jug-loaded PLGA nanoparticles (Jug-PLGA-NPs).
METHODS:
Jug-PLGA-NPs were prepared by ultrasonic emulsification. The anti-tumor activity of Jug (2, 3, 4 µg/mL) and Jug-PLGA-NPs (Jug: 2, 3, 4 µg/mL) in vitro was measured by MTT assay and cell apoptosis analysis. The distribution, anti-tumor effect and biological safety in vivo was evaluated on A375 nude mice.
RESULTS:
With the advantage of good penetration and targeting properties, Jug-PLGA-NPs significantly inhibited proliferation and migration of melanoma cells both in vitro and in vivo (P<0.05 or P<0.01) with acceptable biocompatibility.
CONCLUSIONS
Jug can inhibit the growth of melanoma but is highly toxic. With the advantage of sustained release, tumor targeting, anti-tumor activity and acceptable biological safety, Jug-PLGA-NPs provide a new pharmaceutical form for future application of Jug.
Animals
;
Cell Line, Tumor
;
Delayed-Action Preparations/therapeutic use*
;
Drug Carriers/therapeutic use*
;
Melanoma/pathology*
;
Mice
;
Mice, Nude
;
Nanoparticles
;
Naphthoquinones
;
Particle Size
;
Polylactic Acid-Polyglycolic Acid Copolymer/therapeutic use*
3.High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Yao ZHAO ; Xiaoyu DU ; Yinkai DUAN ; Xiaoyan PAN ; Yifang SUN ; Tian YOU ; Lin HAN ; Zhenming JIN ; Weijuan SHANG ; Jing YU ; Hangtian GUO ; Qianying LIU ; Yan WU ; Chao PENG ; Jun WANG ; Chenghao ZHU ; Xiuna YANG ; Kailin YANG ; Ying LEI ; Luke W GUDDAT ; Wenqing XU ; Gengfu XIAO ; Lei SUN ; Leike ZHANG ; Zihe RAO ; Haitao YANG
Protein & Cell 2021;12(11):877-888
A new coronavirus (SARS-CoV-2) has been identified as the etiologic agent for the COVID-19 outbreak. Currently, effective treatment options remain very limited for this disease; therefore, there is an urgent need to identify new anti-COVID-19 agents. In this study, we screened over 6,000 compounds that included approved drugs, drug candidates in clinical trials, and pharmacologically active compounds to identify leads that target the SARS-CoV-2 papain-like protease (PLpro). Together with main protease (M
Antiviral Agents/therapeutic use*
;
Binding Sites
;
COVID-19/virology*
;
Coronavirus Papain-Like Proteases/metabolism*
;
Crystallography, X-Ray
;
Drug Evaluation, Preclinical
;
Drug Repositioning
;
High-Throughput Screening Assays/methods*
;
Humans
;
Imidazoles/therapeutic use*
;
Inhibitory Concentration 50
;
Molecular Dynamics Simulation
;
Mutagenesis, Site-Directed
;
Naphthoquinones/therapeutic use*
;
Protease Inhibitors/therapeutic use*
;
Protein Structure, Tertiary
;
Recombinant Proteins/isolation & purification*
;
SARS-CoV-2/isolation & purification*
4.Antitumor effect research progress of shikonin and its derivatives.
Meng-Yuan ZHU ; Ru-Bing WANG ; Wen ZHOU ; Shao-Shun LI
Acta Pharmaceutica Sinica 2012;47(5):588-593
Shikonin, the main active ingredient of Lithospermum, and its derivatives have been proved to have antitumor effects, and the anti-tumor mechanisms involve multiple targets. Based on recent literatures, this review focuses on the antitumor effects and its mechanisms. More emphases are given on the aspects of induction of apoptosis, induction of necrosis, acting on matrix metalloproteinase, acting on the protein tyrosine kinase and antiangiogenesis. The current status and problems of shikonin derivatives in antitumor effects are simply summarized and lookout for the development of antitumor drugs with shikonin as leading compounds.
Antineoplastic Agents, Phytogenic
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Apoptosis
;
drug effects
;
Cell Line, Tumor
;
Drugs, Chinese Herbal
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Humans
;
Lithospermum
;
chemistry
;
Matrix Metalloproteinase 9
;
metabolism
;
Naphthoquinones
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Necrosis
;
Neoplasms
;
drug therapy
;
metabolism
;
pathology
;
Neovascularization, Pathologic
;
prevention & control
;
Plants, Medicinal
;
chemistry
;
Protein-Tyrosine Kinases
;
metabolism
;
Reactive Oxygen Species
;
metabolism